Clinical Trials Browser

Mass Spectrometry × Genitourinary × Clear all

NCT01582009 2022-08-15

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Phase 1/2 Terminated

26 enrolled 11 charts

Carcinoma, Renal Cell

NCT00900276 2018-07-05

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Urethral Neoplasms

NCT00373035 2017-01-19

Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy

Prostatic Neoplasms

NCT00984919 2016-02-15

Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers

Prostatic Neoplasms

NCT00459407 2014-10-08

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

Phase 1 Completed

Prostatic Neoplasms

NCT01340599 2012-03-15

Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery

Phase 2 Terminated

Prostatic Neoplasms